Skip to main content

AbbVie Inc. Neuroscience revenue

  • ABBV · NYSE
  • Pharmaceuticals
  • Biotechnology
  • S&P 500
$295.03+0.20%Close 13 Nov 2026 · Market value $524.5B

Neuroscience revenue at AbbVie Inc. came to $3.4B for the quarter to 30 Sep 2026, up 19.3% from a year earlier.

As AbbVie Inc. reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$2.1BDec 2023$2.0BMar 2024$2.2BJun 2024$2.4BSep 2024$2.5BDec 2024$2.3BMar 2025$2.7BJun 2025$2.8BSep 2025$3.0BDec 2025$2.9BMar 2026$3.2BJun 2026$3.4BSep 2026
AbbVie Inc. Neuroscience revenue, every reported period
Period endingNeuroscience revenueChange on a yearFiled
30 Sep 2026$3.4Bup 19.3%30 Oct 2026
30 Jun 2026$3.2Bup 20.3%31 Jul 2026
31 Mar 2026$2.9Bup 26.0%29 Apr 2026
31 Dec 2025$3.0Bup 18.0%4 Feb 2026
30 Sep 2025$2.8Bup 20.2%31 Oct 2025
30 Jun 2025$2.7Bup 24.1%31 Jul 2025
31 Mar 2025$2.3Bup 16.1%25 Apr 2025
31 Dec 2024$2.5Bup 19.8%31 Jan 2025
30 Sep 2024$2.4Bup 15.7%30 Oct 2024
30 Jun 2024$2.2Bup 14.7%25 Jul 2024
31 Mar 2024$2.0Bup 15.9%26 Apr 2024
31 Dec 2023$2.1Bup 22.5%2 Feb 2024
30 Sep 2023$2.0B—27 Oct 2023
30 Jun 2023$1.9B—27 Jul 2023
31 Mar 2023$1.7B—27 Apr 2023
31 Dec 2022$1.7B—9 Feb 2023

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of AbbVie Inc.: Skyrizi revenue · Rinvoq revenue · Botox Therapeutic revenue · Vraylar revenue · Venclexta revenue · Humira revenue · Botox Cosmetic revenue · Imbruvica revenue · Ubrelvy revenue · Qulipta revenue · Creon revenue · Vyalev revenue · Mavyret revenue · Elahere revenue · Juvederm Collection revenue · Linzess/Constella revenue · Ozurdex revenue · Epkinly revenue · Lumigan/Ganfort revenue · Duodopa revenue · Alphagan/Combigan revenue · Immunology revenue · Oncology revenue · Aesthetics revenue · financial statements

Every KPI and segment of ABBV, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.